The product will be launched under Alapis international probiotic brand, which currently carries two products.
Probi will start shipments in the second quarter of 2011 and the product will be launched into Greek pharmacies in the third quarter.
Probi CEO Michael Oredsson said that Alapis Group is a perfect partner for Probi in Greece, with a strong presence and track record in Southeast Europe.
"The launch in Greece is another important milestone for this new product and it is the sixth market where Probi enters into a distribution agreement for the immune tablet," Oredsson said.
Alapis CEO Stylianos Kibaridis said that Probi’s immune product is clinically documented in immune health and common colds and will be sold as a chewable tablet in pharmacies.
Dietary supplements based on Probi’s immune probiotics are now sold or are in the process of being launched in some six countries worldwide.